AI assistant
Hardcore Discoveries Ltd. — Proxy Solicitation & Information Statement 2022
Jan 18, 2022
47887_rns_2022-01-18_4b3af7ff-b6e4-4589-adba-e080161d9d4d.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
==> picture [152 x 72] intentionally omitted <==
Suite�1500�–�1055�West�Georgia�St.�� Vancouver,�British�Columbia�
Tel:�(250)�208�4364�
NOTICE�OF�SPECIAL�MEETING�
The�special�meeting�of�shareholders�of �Makara�Mining�Corp. �(the�“ Company ”)�will�be�held�at�Suite�1500,�1055�West� Georgia�Street,�Vancouver,�British�Columbia,�on�Tuesday,�February�8,�2022�at�10:00�a.m.,�Pacific�Time,�(the� “ Meeting ”).��
*DUE�TO�THE�COVID�19�OUTBREAK,�WE�REQUEST�THAT�ALL�SHAREHOLDERS�VOTE�THEIR�SHARES�BY�PROXY� AND�AVOID�ATTENDING�THE�MEETING�IN�PERSON��*
At�the�Meeting,�Shareholders�will�be�asked�to�consider�the�following�matters�(the�“ Querido�Resolutions ”),�all�of� which�have�been�proposed�by�Noel�Querido�(“ Querido ”),�a�Shareholder�which�holds�in�excess�of�5%�of�the� Company’s�outstanding�common�shares�and�is�therefore�entitled�to�requisition�the�Meeting:�
-
A�special�resolution�to�remove�the�following�directors�of�the�Company�from�the�Board:�
-
Grant�Hendrickson�
-
Hugh�Maddin�
-
Andrew�H.�von�Kursell;�and�
-
Uranbileg�Yondon�
(the�“ Resolution�to�Remove�Directors ”)�
-
If�the�resolution�to�remove�Grant�Hendrickson,�Hugh�Maddin,�Andrew�H.�von�Kursell�and�Uranbileg�Yondon� as�directors�is�passed,�then�shareholders�will�be�asked�to�consider�an�ordinary�resolution�to�set�the�number� of�directors�of�the�Company�at�three�directors,�or�such�other�number�as�may�be�determined�at�the�Meeting� (the�“ Resolution�to�Set�the�Board�at�Three ”);�and�
-
An�ordinary�resolution�to�elect�Querido’s�nominee,�David�Greenway,�businessman�of�Vancouver�BC�as�a� director�of�the�Company�(the�“ Resolution�to�Elect�the�Querido�Nominee ”).�
An�Information�Circular�accompanies�this�Notice�and�contains�details�of�matters�to�be�considered�at�the�Meeting.��A� copy�of�the�Notice�of�Requisition�of�Meeting�that�was�provided�to�the�Company�by�Mr.�Querido�on�October�8,�2021� (the�“Requisition”)�and�is�attached�as�Schedule�A�to�the�Information�Circular.��No�other�matters�are�contemplated,� however,�any�permitted�amendment�to�or�variation�of�any�matter�identified�in�this�Notice�may�properly�be� considered�at�the�Meeting.�
T he�Special�Committee�of�the�Board�of�Directors�of�the�Company,�comprised�of�Grant�Hendrickson,�Hugh�Maddin� and�Andrew�H.�von�Kursell,�recommend�that�Shareholders�reject�the�Querido�Resolutions�and�vote:�
-
1.�� AGAINST�THE�RESOLUTION�TO�REMOVE�DIRECTORS�GRANT,�HUGH,�ANDREW�AND�URANBILEG�FROM� THE�BOARD�
-
2.� AGAINST�THE�RESOLUTION�TO�SET�THE�BOARD�AT�THREE�DIRECTORS��
-
3.�� AGAINST�THE�RESOLUTION�TO�ELECT�THE�QUERIDO�NOMINEE,�DAVID�GREENWAY,�TO�THE�BOARD�
Registered�shareholders�who�are�unable�to�attend�the�Meeting�in�person�and�who�wish�to�ensure�their�Common� Shares�are�voted�at�the�Meeting�are�asked�to�complete,�date�and�sign�the�enclosed�form�of�Proxy,�or�another� suitable�form�of�proxy,�and�deliver�it�in�accordance�with�the�instructions�set�out�in�the�form�of�proxy�and�in�the� Information�Circular.�
Non�registered�(beneficial)�shareholders�who�plan�to�attend�the�Meeting�must�follow�the�instructions�set�out�in� the�Proxy�or�Voting�Instruction�Form�to�ensure�their�shares�are�voted�at�the�Meeting.��If�you�hold�your�shares�in�a� brokerage�account�you�are�a�non�registered�(beneficial)�shareholder.�
In�light�of�the�ongoing�public�health�concerns�related�to�COVID�19�and�in�order�to�comply�with�measures�imposed� by�the�federal�and�provincial�governments,�the�Company�is�encouraging�Shareholders�and�others�not�to�attend� the�Meeting�in�person,�but�instead�to�submit�their�votes�by�proxy�well�in�advance�of�the�Meeting�proxy�deadline� of�10:00�a.m.�(Pacific�Time)�on�February�4,�2022.��Shareholders�who�wish�to�attend�the�Meeting�in�person�must� call�the�Company�(250)�208�4364�at�least�48�hours�prior�to�the�date�of�the�Meeting�for�further�instructions�on�in� person�attendance�procedures.
At�the�date�of�this�Notice�and�the�accompanying�Information�Circular�it�is�the�intention�of�the�Company�to�hold�the� Meeting�at�the�location�stated�above�in�this�Notice.�We�continue�to�monitor�development�of�the�current�coronavirus� (COVID�19)�outbreak�(the�“ COVID�19�outbreak ”).��In�light�of�evolving�public�health�guidelines�related�to�the�COVID� 19�outbreak,�we�ask�shareholders�to�consider�voting�their�shares�by�proxy�and�not�attend�the�meeting�in�person.� Those�shareholders�who�wish�to�attend�the�Meeting�in�person,�should�carefully�consider�and�follow�the�instructions� of�the�federal�Public�Health�Agency�of�Canada�available�at:��https://www.canada.ca/en/public� health/services/diseases/coronavirus�disease�covid�19.html.�We�ask�that�shareholders�also�review�and�follow�the� instructions�of�any�regional�health�authorities�of�the�Province�of�British�Columbia,�including�the�Vancouver�Coastal� Health�Authority,�the�Fraser�Health�Authority�and�any�other�health�authority�holding�jurisdiction�over�the�areas�you� must�travel�through�to�attend�the�Meeting.��Do�not�attend�the�Meeting�in�person�if�you�are�experiencing�any�cold�or� flu�like�symptoms,�or�if�you�or�someone�with�whom�you�have�been�in�close�contact�has�travelled�to/from�outside�of� Canada�within�the�14�days�immediately�prior�to�the�Meeting.�All�shareholders�are�strongly�encouraged�to�vote�by� submitting�their�completed�form�of�proxy�(or�voting�instruction�form)�prior�to�the�Meeting�by�one�of�the�means� described�in�the�Information�Circular�accompanying�this�Notice.�
The�Company�reserves�the�right�to�take�any�additional�pre�cautionary�measures�deemed�to�be�appropriate,� necessary�or�advisable�in�relation�to�the�Meeting�in�response�to�further�developments�in�the�COVID�19�outbreak,� including:�(i)�holding�the�Meeting�virtually�or�by�providing�a�webcast�of�the�Meeting;�(ii)�hosting�the�Meeting�solely� by�means�of�remote�communication;�(iii)�changing�the�Meeting�date�and/or�changing�the�means�of�holding�the� Meeting;�(iv)�denying�access�to�persons�who�exhibit�cold�or�flu�like�symptoms,�or�who�have,�or�have�been�in�close� contact�with�someone�who�has,�travelled�to/from�outside�of�Canada�within�the�14�days�immediately�prior�to�the� Meeting;�(v)�denying�access�to�persons�that�do�not�have�evidence�of�full�vaccination�or�a�negative�COVID�19�rapid� test�result�completed�within�24�hours�immediately�prior�to�the�Meeting,�and�(vi)�such�other�measures�as�may�be� recommended�by�public�health�authorities�in�connection�with�gatherings�of�persons�such�as�the�Meeting.��Should� any�such�changes�to�the�Meeting�format�occur,�the�Company�will�announce�any�and�all�of�these�changes�by�way�of� news�release,�which�will�be�filed�under�the�Company’s�profile�on�SEDAR.�We�strongly�recommend�you�check�the� Company’s�SEDAR�profile�prior�to�the�Meeting�for�the�most�current�information.�In�the�event�of�any�changes�to�the�
��2���
Meeting�format�due�to�the�COVID�19�outbreak,�the�Company�will�not�prepare�or�mail�amended�Meeting�Proxy� Materials.�
DATED�at�Vancouver,�British�Columbia,�January�12,�2022.�
BY�ORDER�OF�THE�BOARD�
“Grant�Hendrickson”�
Grant�Hendrickson� Chief�Executive�Officer�and�Director
��3���